-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
In 2015, more than 46 million people worldwide were diagnosed with dementia, and this number is expected to increase to 131 million by 2050
Diagnosis and management to prevent vascular diabetes and cholesterol
Recently, a research article was published in Hypertension, an authoritative cardiovascular journal, in which researchers investigated the association between blood pressure and the risk of dementia subtypes through antihypertensive treatment and comorbidities
Cardiovascular
The researchers used the Korean National Health Insurance Service-Health Screening database from 2009 to 2012 to analyze 4,522,447 adults over 60 years old with no history of dementia, and followed up for an average of 5.
Screening
In the group with SBP≥160mmHg and lower SBP, the risk of overall dementia and possible Alzheimer's disease was significantly higher
In summary, the possible Alzheimer's disease and the possible VaD risk are different in individuals with lower blood pressure
The possible Alzheimer's disease and the possible VaD risk are different in individuals with lower blood pressure
Original source:
Chan Joo Lee.
